Voluntary Removal of Opioid Opana ER from the Market

Posted by Stephanie Labonville on Aug 2, 2017 8:00:00 AM

Endo Pharmaceuticals Inc. recently released news that it will voluntarily remove Opana ER from the market, with planned shipments slated to end September 1, 2017.  This news follows the Food and Drug Administration’s (FDA) June 2017 request to withdraw Opana ER from the market due to risks related to abuse. 

Read More

Topics: Clinical

How do I Know If I'm at Risk for Opioid Abuse or Misuse?

Posted by Stephanie Labonville on Jul 6, 2017 10:12:06 AM

With opioid abuse and misuse so prevalent today, it is important to understand the scale of the issue and be aware that certain factors might put you or someone you know at risk for developing opioid addiction, abuse, harm or misuse. 

Read More

Topics: Clinical, Pain Management

Topical Compound Medications: An Alternative to Oral Medications

Posted by Stephanie Labonville on May 11, 2017 8:00:00 AM

Topical compound medications are typically not the first choice for treatment of pain from a workplace injury, but they can be useful in some situations.

Read More

Topics: Clinical, Pain Management

Generic vs. Brand: What's the Difference?

Posted by Stephanie Labonville on Apr 19, 2017 8:00:00 AM

According to the FDA, nearly 8 in 10 prescriptions filled in the United States are for generic drugs.  That statistic may lead to the question, what are generic drugs and why are they apparently used more often than brand drugs?  To answer that question, it is important to understand a little bit about how drugs are developed and come to market. 

Read More

Topics: Clinical

Opiate, Opioid, Narcotic - What's the Difference?

Posted by Stephanie Labonville on Mar 29, 2017 8:00:00 AM

The terms opiate, opioid and narcotic are often used in what would seem the same way. With prescription pain medications reaching their highest point in years, it’s wise to know the difference between each of these terms and how they work.

Read More

Topics: Clinical

Are Tamper Resistant Drugs a Way to Curb the Opioid Epidemic?

Posted by Stephanie Labonville on Feb 23, 2017 8:00:00 AM

Tamper resistant and abuse deterrent opioid formulations are designed to make drugs difficult or less desirable to use in any manner other than how they were prescribed.  The formulations make them harder to crush, chew, cut, dissolve, inhale, inject, or less rewarding if done so, thus deterring use in many of the ways they are abused.   With the goal of combatting the opioid epidemic, the “FDA is encouraging the development of opioid formulations with abuse-deterrent properties”.

Read More

Topics: Clinical, Pain Management

Tips For Tapering Medication

Posted by Stephanie Labonville on Feb 8, 2017 10:26:07 AM

It’s become clear that excessive use of opioids is a problem.   According to the Centers for Disease Control and Prevention (CDC), prescription opioids are considered a driving force in the 15-year increase in opioid-related deaths with 91 Americans dying every day from an opioid overdose. What can be done to decrease these overdoses? Many factors and opinions play into the decisions around how best to tackle this problem.

Read More

Topics: Clinical, Pain Management

Weighing the Risks and Benefits of Medication Treatment Options

Posted by Stephanie Labonville on Jan 26, 2017 10:53:45 AM

When it comes to taking medications, it’s important to make decisions about continuing, changing or stopping them based off an understanding of the potential for both risks and benefits.  Medications should only be used if the benefits outweigh the potential harms or risks.

Read More

Topics: Clinical

Get Involved During National Drug & Alcohol Facts Week

Posted by Stephanie Labonville on Jan 20, 2017 12:30:40 PM

Today marks the beginning of National Drug & Alcohol Facts Week (NDAFW). This week is devoted to minimizing the negative impact drugs and alcohol can have by educating young people using science from the National Institute of Drug Abuse (NIDA) to dispel potentially harmful drug and alcohol myths.

Read More

Topics: Clinical

Adverse Drug Reactions: What to Know

Posted by Stephanie Labonville on Jan 11, 2017 4:05:28 PM

Adverse drug reactions (ADR) cause between 5-7% of all hospitalizations, and result in over 140,000 fatalities annually.  These staggering statistics highlight why it is so important to understand what ADRs are and what can be done about them. 

Read More

Topics: Clinical

Blog Subscription

Peace of Mind, Delivered.

IWP is a specialized workers' compensation pharmacy service that delivers prescription medications directly to the doorstep of injured individuals nationwide.